2024 Annual Meeting | C67 - Therapy in Neurology 2

Date Sunday 04/14/24

Time 03:30 PM - 05:30 PM MDT Add To Calendar

Location Colorado Convention Center | Bluebird 2E-H

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) James Conners, MD

Topic(s) Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Infectious Disease, Movement Disorders

Learning Objectives Participants should be able to describe the most recent advances in the treatment of Alzheimer's disease and MS, as well as emerging gene therapy for neuromuscular disease, and offer these treatments to their patients. This program complements Therapy in Neurology 1 but covers independent topics

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Non-neurologist, Advanced Practice Provider

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
03:30 PM - 04:05 PM MDT	Speaker	Gene Therapy in Neuromuscular Disease Emma Ciafaloni, MD, FAAN
04:05 PM - 04:40 PM MDT	Speaker	Updates in Multiple Sclerosis Therapy Augusto A. Miravalle, MD, FAAN
04:40 PM - 05:15 PM MDT	Speaker	Emerging Therapeutics for Alzheimer Disease B. J. Snider, MD, PhD, FAAN
05:15 PM - 05:30 PM MDT	Q&A	Questions & Answers Emma Ciafaloni, MD, FAAN, Augusto A. Miravalle, MD, FAAN, B. J. Snider, MD, PhD, FAAN

Faculty Disclosures
James Conners, MD	The institution of Dr. Conners has received research support from nih.
B. J. Snider, MD, PhD, FAAN	Dr. Snider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum . Dr. Snider has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. The institution of Dr. Snider has received research support from NIH. The institution of Dr. Snider has received research support from Eisai. The institution of Dr. Snider has received research support from Biogen. The institution of Dr. Snider has received research support from Alzheimer Clinical Trials Consortium. The institution of Dr. Snider has received research support from Eli Lilly. The institution of Dr. Snider has received research support from Hoffman La Roche. The institution of Dr. Snider has received research support from Janssen.
Emma Ciafaloni, MD, FAAN	Dr. Ciafaloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx, Alexion, Sarepta, UCB, Hoffman-LaRoche, Biogen. Dr. Ciafaloni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, AnnJi Pharmaceutical, ML-BIO, Avidity. The institution of Dr. Ciafaloni has received research support from CDC, CureSMA, FDA, Orphazyme, Sarepta, PCORI, Neurogene. Dr. Ciafaloni has received publishing royalties from a publication relating to health care.
Augusto A. Miravalle, MD, FAAN	Dr. Miravalle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Miravalle has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Miravalle has received research support from Genzyme. The institution of Dr. Miravalle has received research support from EMD Serono. The institution of Dr. Miravalle has received research support from Alexion.